Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084819

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084819

Prothrombin Complex Concentrates Market, By Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 254 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Prothrombin Complex Concentrates Market is estimated to be valued at USD 1,253.4 Mn in 2026 and is expected to reach USD 2,473.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,253.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.20% 2033 Value Projection: USD 2,473.7 Mn

Prothrombin complex concentrates (PCCs) are highly purified concentrate prepared from blood plasma with hemostatic activity contain four vitamin K-dependent clotting factors (F) (II (prothrombin), VII, IX and X), for replacement therapy in patients with congenital or acquired deficiencies.

Moreover, in several European countries, prothrombin complex concentrates are also used in the management of massive peri- and postoperative bleeding.

Market Dynamics

Global Prothrombin Complex Concentrates Market is expected to show significant growth, owing to increasing approval of product. For instance, in 2013, the U.S Food and Drug Administration (FDA) accepted Octapharma USA's Biological License Application (BLA) for octaplex 4-Factor PCC, for indication of reversal of anticoagulation therapy in patients undergoing vitamin K antagonist therapy with the need for urgent surgery or invasive procedures

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prothrombin complex concentrates market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Octapharma AG, Nihon Pharmaceutical Co Ltd, Grifols S.A., CSL Behring GmbH, Kedrion Biopharma Inc., Shire Plc, China Biologic Products Holdings, Inc., and Sanquin
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prothrombin complex concentrates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prothrombin complex concentrates market

Market Segmentation

  • By Type (Revenue, USD Mn, 2021-2033)
  • 3-Factor PCC
  • 4-Factor PCC
  • By Application (Revenue, USD Mn, 2021-2033)
  • Acquired Coagulation Factor Deficiency
  • Congenital Coagulation Factor Deficiency
  • Others
  • By End User (Revenue, USD Mn, 2021-2033)
  • Hospital
  • Ambulatory Surgical Centres
  • Others
  • By Region (Revenue, USD Mn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
  • Octapharma AG
  • Nihon Pharmaceutical Co. Ltd.
  • Grifols S.A.
  • CSL Behring GmbH
  • Kedrion Biopharma Inc.
  • Shire Plc
  • China Biologic Products Holdings, Inc.
  • Sanquin
Product Code: CMI4647

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Prothrombin Complex Concentrates Market, By Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • 3-Factor PCC
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • 4-Factor PCC
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Prothrombin Complex Concentrates Market, By Application, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Acquired Coagulation Factor Deficiency
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Congenital Coagulation Factor Deficiency
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Prothrombin Complex Concentrates Market, By End User, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Ambulatory Surgical Centres
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Prothrombin Complex Concentrates Market, By Region, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Octapharma AG
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Nihon Pharmaceutical Co. Ltd.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Grifols S.A.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • CSL Behring GmbH
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Kedrion Biopharma Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Shire Plc
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • China Biologic Products Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Sanquin
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!